Business Context and Reporting Period
Healthcare Triangle, Inc. (HCTI), a Delaware corporation, filed this Form 8-K on November 28, 2025, to report the results of its virtual 2025 Special Stockholders Meeting held on the same date. The company is listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material event reported is the successful approval of a stockholder proposal to authorize future securities issuances. As of the record date (November 12, 2025), the company had 7,261,344 shares of common stock and 20,000 shares of Series A Super Voting preferred stock outstanding. A quorum was established with approximately 74.27% of outstanding voting shares represented at the meeting.
Guidance, Outlook, and Management Commentary
The filing details the approval of the "Nasdaq Approval Proposal" under Nasdaq Listing Rule 5635(d). This proposal authorizes the issuance of the Company's securities up to an aggregate amount of $70 million during the three-month period following November 28, 2025, provided each issuance meets specific Nasdaq parameters. The proposal passed with 20,095,715 votes in favor, 149,021 against, and 1,618 abstentions. No forward-looking financial guidance or risk factors were disclosed in this specific filing.
Investor Verification Checklist
- Verify the specific "Nasdaq Parameters" referenced in the Proxy Statement to understand the conditions under which the $70 million in future issuances can occur.
- Confirm the exact closing date of the three-month issuance window (approximately February 28, 2026).
- Review the company's subsequent filings to determine if and when any securities are issued under this new authorization.
- Check the current share count to monitor dilution if the $70 million authorization is utilized.